Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Skrbic, Ranko
NCT05416580: Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes	Enrolling by invitation	3	60	RoW	UDCA (Ursodeoxycholic acid), Ursofalk, Bilexin, Placebo, Metformin, Siofor, Glucophage	University of Banja Luka	Diabetes Mellitus, Type 2	03/24	04/24
Lakic, Biljana
NCT05416580: Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes	Enrolling by invitation	3	60	RoW	UDCA (Ursodeoxycholic acid), Ursofalk, Bilexin, Placebo, Metformin, Siofor, Glucophage	University of Banja Luka	Diabetes Mellitus, Type 2	03/24	04/24
Stokanovic, Anastasija
NCT05416580: Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes	Enrolling by invitation	3	60	RoW	UDCA (Ursodeoxycholic acid), Ursofalk, Bilexin, Placebo, Metformin, Siofor, Glucophage	University of Banja Luka	Diabetes Mellitus, Type 2	03/24	04/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Skrbic, Ranko
NCT05416580: Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes	Enrolling by invitation	3	60	RoW	UDCA (Ursodeoxycholic acid), Ursofalk, Bilexin, Placebo, Metformin, Siofor, Glucophage	University of Banja Luka	Diabetes Mellitus, Type 2	03/24	04/24
Lakic, Biljana
NCT05416580: Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes	Enrolling by invitation	3	60	RoW	UDCA (Ursodeoxycholic acid), Ursofalk, Bilexin, Placebo, Metformin, Siofor, Glucophage	University of Banja Luka	Diabetes Mellitus, Type 2	03/24	04/24
Stokanovic, Anastasija
NCT05416580: Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes	Enrolling by invitation	3	60	RoW	UDCA (Ursodeoxycholic acid), Ursofalk, Bilexin, Placebo, Metformin, Siofor, Glucophage	University of Banja Luka	Diabetes Mellitus, Type 2	03/24	04/24